Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome
- 18 November 2017
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 178 (6) , 1430-1432
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 8 references indexed in Scilit:
- Involvement of Human Herpesvirus 6 Infection in Renal Dysfunction Associated with DIHS/DRESSActa Dermato-Venereologica, 2016
- Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entitiesEuropean Journal Of Dermatology, 2015
- Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)British Journal of Dermatology, 2014
- Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)Journal of Dermatological Science, 2013
- Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndromeBritish Journal of Dermatology, 2007
- The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivationsBritish Journal of Dermatology, 2007
- Real-Time Quantitative PCR Assays for Detection andMonitoring of Pathogenic Human Viruses in ImmunosuppressedPediatricPatientsJournal of Clinical Microbiology, 2004
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994